PATENT CLAIM ANALYSIS

Application Number: 16226070
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["514", "210200"]

Abstract:
Provided are a pyrimidine compound represented by Formula 1, a method of preparing the same, and a pharmaceutical use of the pyrimidine compound for the prevention or treatment of cancer.

Claim (Index 5):
The compound of  claim 1 , wherein R 7  is a cyclopropyl group.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 98.0
- Lexical Diversity: 1.375
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16127487', '15319151', '12843494', '15565897', '12002340']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8132268278440203
- 35 USC 102 Novelty (BERT): 0.6114364139138108
- Combined Prediction Score: 0.7930477864509994
- Mean Citation Score: 352.326112
- Max Citation Score: 527.59644
- Similarity Product: 522.1374579369162

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test